Renault's best-selling Vuse e-cigarette continues to widen the gap with Juul in monthly and annual comparisons.
According to the latest report, Vuse's market share has increased from 40.7% to 41.1%, while Juul's has decreased from 27% to 26.7%. Throughout 2022, Vuse maintained a market share of 35.7%, while Juul's sat at 30.1%.
NJoy, ranked third, has dropped from 2.8% to 2.7%, while Fontem Ventures' blu eCigs maintains at 1.4%.
According to media reports, Juul's four-week US sales revenue has declined from 50.2% on August 10, 2019, to 23.7% in the latest report.
In contrast, Renault's Vuse increased by 32.7% in the latest report, while NJoy increased by 0.1%. blu eCigs declined by 33.4%, and Japan Tobacco's Logic fell by 15.1%.
As of May 2019, Juul maintained a 74.6% share of the electronic cigarette market in the United States.
On September 30th, Altria Group Inc. cleared the way for re-entry into the electronic cigarette market by choosing to permanently terminate its non-compete agreement with Juul.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
